MGC Diagnostics (MGCD) Announces Study to Evaluate Diagnostic Accuracy of FOT to Detect Lung Function Abnormalities
Tweet Send to a Friend
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced a new clinical study collaboration with Restech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
